U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from OMIM

Items: 4

1.
CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy
Amira A Barkal, Rachel E. Brewer, Maxim Markovic, Mark Kowarsky, Sammy A Barkal, Balyn W. Zaro, Venkatesh Krishnan, Jason Hatakeyama, Oliver Dorigo, Layla J Barkal, Irving L. Weissman
Nature. Author manuscript; available in PMC 2020 Jan 31.
Published in final edited form as: Nature. 2019 Aug; 572(7769): 392–396. Published online 2019 Jul 31. doi: 10.1038/s41586-019-1456-0
PMCID:
PMC6697206
AbstractArticlePDF–4.8M
2.
CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
Guo-Yun Chen, Jie Tang, Pan Zheng, Yang Liu
Science. Author manuscript; available in PMC 2009 Oct 22.
Published in final edited form as: Science. 2009 Mar 27; 323(5922): 1722–1725. Published online 2009 Mar 5. doi: 10.1126/science.1168988
PMCID:
PMC2765686
AbstractArticlePDF–1.2M
3.
Massive and destructive T cell response to homeostatic cue in CD24-deficient lymphopenic hosts
Ou Li, Xing Chang, Huiming Zhang, Ergun Kocak, Cheng Ding, Pan Zheng, Yang Liu
J Exp Med. 2006 Jul 10; 203(7): 1713–1720. doi: 10.1084/jem.20052293
PMCID:
PMC2118348
AbstractArticlePDF–2.5M
4.
CD24 is expressed by myofiber synaptic nuclei and regulates synaptic transmission
Marko Jevsek, Alexander Jaworski, Luis Polo-Parada, Natalie Kim, Jihua Fan, Lynn T. Landmesser, Steven J. Burden
Proc Natl Acad Sci U S A. 2006 Apr 18; 103(16): 6374–6379. Published online 2006 Apr 10. doi: 10.1073/pnas.0601468103
PMCID:
PMC1435367
AbstractArticlePDF–1.6M

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center